Literature DB >> 20638620

Shock wave-pretreated bone marrow cells further improve left ventricular function after myocardial infarction in rabbits.

Jiunn-Jye Sheu1, Cheuk-Kwan Sun, Li-Teh Chang, Hsiu-Yu Fang, Sheng-Ying Chung, Sarah Chua, Morgan Fu, Fan-Yen Lee, Ying-Hsien Kao, Sheung-Fat Ko, Ching-Jen Wang, Chia-Hung Yen, Steve Leu, Hon-Kan Yip.   

Abstract

BACKGROUND: We tested whether shock wave (SW) offers additional benefits in improving left ventricular (LV) function after acute myocardial infarction (AMI) in rabbits receiving SW-treated autologous bone marrow-derived mononuclear cells (BMDMNCs) transplantation. METHODS AND
RESULTS: Saline (750 microL; group 2), BMDMNCs (1.0 x 10(7); group 3), or preimplant SW-treated BMDMNCs (group 4) were implanted into the infarct area of male rabbits 15 minutes after left coronary artery ligation, whereas eight rabbits without AMI served as controls (group 1; n = 8 per group). The results showed that in infarct area of LV, protein expressions of Cx43 and cytochrome C in mitochondria and endothelial nitric oxide synthase mRNA expression were lower in group 2 than in other groups, and decreased in group 3 as compared with groups 1 and 4 (all p values < 0.01). Conversely, mRNA expressions of endothelin-1 and matrix metalloproteinase-9, mitochondrial oxidative stress, and total fibrotic area were higher in group 2 than in other groups (all p values < 0.05). Furthermore, 6-month LV function by 2-D echo/angiogram showed significant impairment in group 2 than in other groups and in group 3 than in groups 1 and 4 (all p values < 0.005).
CONCLUSIONS: Application of SW-treated autologous BMDMNCs is superior to BMDMNCs alone for preserving LV function after AMI. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638620     DOI: 10.1016/j.avsg.2010.03.027

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  4 in total

Review 1.  Dysregulation of Mfn2 and Drp-1 proteins in heart failure.

Authors:  Srikanth Givvimani; Sathnur Pushpakumar; Sudhakar Veeranki; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2014-05-09       Impact factor: 2.273

2.  The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.

Authors:  Gianluca Alunni; Sebastiano Marra; Ilaria Meynet; Maurizio D'amico; Pelloni Elisa; Annalaura Fanelli; Stefano Molinaro; Paolo Garrone; Armando Deberardinis; Mario Campana; Amir Lerman
Journal:  Cardiovasc Revasc Med       Date:  2014-11-10

Review 3.  Extracorporeal shockwave therapy in musculoskeletal disorders.

Authors:  Ching-Jen Wang
Journal:  J Orthop Surg Res       Date:  2012-03-20       Impact factor: 2.359

4.  Extracorporeal Cardiac Shock Waves Therapy Improves the Function of Endothelial Progenitor Cells After Hypoxia Injury via Activating PI3K/Akt/eNOS Signal Pathway.

Authors:  Mingqiang Wang; Dan Yang; Zhao Hu; Yunke Shi; Yiming Ma; Xingyu Cao; Tao Guo; Hongbo Cai; Hongyan Cai
Journal:  Front Cardiovasc Med       Date:  2021-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.